Status:
COMPLETED
Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD
Lead Sponsor:
Calvary Hospital, Bronx, NY
Conditions:
PVD
Arterial Ulcers
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
To evaluate the effects of HPIPC for the treatment of symptoms of PAD
Eligibility Criteria
Inclusion
- Intermittent claudication \>6mo
- Ischemic ulceration or ulcer of mixed (venous) etiology
- ABI \< 0.7
- Ambulatory
- Able to comply
Exclusion
- Gangrene
- M.I. within 6mo
- Inability to walk
- Wound infection
- Systemic corticosteroids
- HBO, Apligraf, Dermagraft within 6mo
- Falsely elevated ankle to brachial index (ABI)
- Inflammatory condition affecting healing
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01420289
Start Date
January 1 2009
End Date
June 1 2011
Last Update
February 9 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Curative and Palliative wound Care, Calvary Hospital
The Bronx, New York, United States, 10461